← Back to Search

Reengagement and Assessment Mobile Program for HIV/AIDS

N/A
Waitlist Available
Led By Christopher Sellers, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months following participants' last intervention visit
Awards & highlights

Study Summary

This trial is designed to help out of care HIV+ patients who have not reengaged in care following the standard of care. It will provide them with an "on-ramp" to HIV care consisting of up to 4 visits from an outreach research nurse.

Eligible Conditions
  • HIV/AIDS

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months following participants' last intervention visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months following participants' last intervention visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of eligible persons screened that enroll.
Qualitative Summary of Participants' Experiences from In-depth Baseline Interview
Qualitative Summary of Participants' Experiences from In-depth Exit Interview
Secondary outcome measures
Number of participants who are successfully reengaged following the intervention.
Number of participants who are successfully retained following the intervention.
Number of participants who have viral suppression following the intervention.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care Reengagement GroupExperimental Treatment1 Intervention
This group will complete a qualitative interview about barriers and facilitators to HIV care.
Group II: Intervention GroupExperimental Treatment2 Interventions
This group will complete an HIV health reengagement intervention on a mobile van, in addition to a pre- and post-intervention qualitative interview.
Group III: Non-enrolling GroupActive Control1 Intervention
This group will not be enrolled in the intervention, and will include de-identified data from clinic patients referred to bridge counselors during the study time period that do not participate in the intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reengagement and Assessment Mobile Program
2020
N/A
~30

Find a Location

Who is running the clinical trial?

ViiV HealthcareIndustry Sponsor
359 Previous Clinical Trials
468,513 Total Patients Enrolled
University of North Carolina, Chapel HillLead Sponsor
1,504 Previous Clinical Trials
4,187,632 Total Patients Enrolled
Christopher Sellers, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
HIV Reengagement and Assessment Mobile Program (Project RAMP)
2020. "HIV Reengagement and Assessment Mobile Program (Project RAMP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04151498.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top